Press releases

November 4, 2026

Limbus Medical Technologies achieves C5 attestation for the varvis® software

Limbus Medical Technologies GmbH, a medical device manufacturer and software development company based in Rostock, Germany, has achieved C5 attestation (type 1). This milestone reinforces the company's commitment to information security in cloud-based clinical genomics. For laboratories and hospitals, the result is a certified, secure cloud service that supports their compliance requirements.

Read more


September 15, 2025

Limbus acquires Nostos: Accelerating the path to Europe’s leading genetic diagnostics software solution

Limbus, the company behind the innovative varvis® software for genomic data analysis, today announced the acquisition of Nostos Genomics, a fellow pioneer in AI-driven medical software solutions. This acquisition unites two leaders in genomic software—combining Limbus’ clinical-grade workflows with Nostos’ cutting-edge AI technology for variant interpretation.

Read more


June 1, 2024

The varvis® software: The first genomics end-to-end software certified as IVDR Class C device

Genetic diagnostic laboratories now have access to the first complete genomics software solution which is certified as a Class C device under IVDR. This will significantly reduce the effort required for legally compliant documentation of in-house tests.

Read more